MoneyWorks4Me

USFDA issues no observations to Ajanta Pharma's Dahej plant

10 Apr 2017 Evaluate

Ajanta Pharma’s formulation facility at Dahej was inspected by US Food and Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no Form 483 was issued to the company.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..